Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 22:2020:9524839.
doi: 10.1155/2020/9524839. eCollection 2020.

Relationship between Prolactin, Chronic Kidney Disease, and Cardiovascular Risk

Affiliations
Review

Relationship between Prolactin, Chronic Kidney Disease, and Cardiovascular Risk

Marclébio Dourado et al. Int J Endocrinol. .

Abstract

CKD has a high prevalence worldwide, mainly due to its main etiologies-diabetes and hypertension. It has high cardiovascular morbidity and mortality, with traditional risk factors such as atherosclerosis, hypertension, diabetes, smoking, and left ventricular hypertrophy being common. Nontraditional cardiovascular risk factors, such as anemia, hyperparathyroidism, chronic inflammation, and microalbuminuria, are also well studied. Prolactin is a hormone not only related to lactation but also being considered a uremic toxin by some authors. It accumulates with loss of renal function, and it is associated with cardiovascular outcomes in both normal renal function population and CKD population. The purpose of this narrative review is to raise the main common aspects of CKD, prolactinemia, and cardiovascular risk.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this paper.

References

    1. Xie Y., Bowe B., Mokdad A. H., et al. Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney International. 2018;94(3):567–581. doi: 10.1016/j.kint.2018.04.011. - DOI - PubMed
    1. Xian M. M. Peripartum cardiomyopathy. Circulation. 2013;127(20):622–627. doi: 10.1161/circulationaha.113.001851. - DOI - PubMed
    1. Haring R., Friedrich N., Volzke H., et al. Positive association of serum prolactin concentrations with all-cause and cardiovascular mortality. European Heart Journal. 2014;35(18):1215–1221. doi: 10.1093/eurheartj/ehs233. - DOI - PubMed
    1. Friedrich J. J., Kyriazis J., Sonmez A., et al. Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD. Clinical Journal of the American Society of Nephrology. 2012;7(2):207–215. doi: 10.2215/cjn.06840711. - DOI - PMC - PubMed
    1. Tzanakis N. D., Gregerson K. A. Prolactin actions. Journal of Molecular Endocrinology. 2013;52(1):95–106. - PubMed

LinkOut - more resources